Aids experts denounce vaccine trial

A LARGE-SCALE trial of an Aids vaccine has been denounced by leading British scientists as a waste of time and money because few, if any, of the 5,000 volunteers will benefit.

The trial, which began this week, will result in people at risk of Aids in 30 American cities being injected with a prototype vaccine made from a synthetic protein designed to mimic the outer coating of HIV.

VaxGen, a private biotechnology company based in San Francisco, has received approval from the US Food and Drug Administration to go ahead with the phase three trial, which is usually the last stage before going on sale. It is the first of more than 40 Aids vaccine trials to get this far in the testing procedure. It will be given to half of the volunteers, who are all considered at risk of HIV infection. The other half will be given a harmless placebo.

Neither the scientists nor the volunteers will know who has been given the vaccine and who has the placebo until the end of the 30-month experiment, when the infection rates of the two groups will be compared to see if the vaccine has prevented HIV transmission.

VaxGen said its vaccine is modelled on an HIV protein called gp120. This protein has been of interest to Aids researchers for nearly 15 years because of the possibility of it being used to make vaccines that will stimulate the body's immune defences to attack HIV.

Scientists this month completed the first detailed, three-dimensional images of the structure of gp120. However, the new findings suggest that the VaxGen vaccine will be unable to stimulate an effective immune response in the volunteers because it is too dissimilar to natural gp120.

Andrew McMichael, professor of immunology at Oxford University and one of Britain's leading experts in Aids vaccine research, said: "I think the leading immunologists and virologists in the field are pretty unanimous in their view. The likelihood that [the vaccine] is not going to do anything is quite high."

Professor McMichael said the reasons why the trial is going ahead are more to do with ``business and politics'' than with science.

The vaccine is supposed to work by stimulating a patient's antibodies to attack the gp120 protein on HIV. However, the natural protein and the synthetic vaccine are too different for this to work with any great effect, he said.

``On theoretical grounds the chances are low. But preliminary trials earlier this year suggested that some vaccinated people still became infected. So really there was quite good negative evidence that this was not an effective vaccine,'' he said.

The reservations about vaccines based on gp120 are shared by dozens of American Aids specialists who recently signed a letter to the journal Science supporting a decision not to begin trials until problems with the vaccine's potency can be resolved.

Attempts to develop an Aids vaccine have met with problems because of the unique nature of HIV. It mutates rapidly, even within one person, so evading the best efforts of a vaccine to stimulate effective immunity.

Albert Sabin, who pioneered the development of a polio vaccine, warned just before be died in 1993 that it would be virtually impossible for any Aids vaccine to work. The virus he said was also able to escape the immune defences by infecting the cells that are sent to destroy it.

Suggested Topics
Start your day with The Independent, sign up for daily news emails
Have you tried new the Independent Digital Edition apps?
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Recruitment Genius: SAGE Bookkeeper & PA to Directors

£18000 - £24000 per annum: Recruitment Genius: An exciting opportunity has ari...

Recruitment Genius: Online Sales and Customer Services Executive

£15000 - £18000 per annum: Recruitment Genius: An On-line Sales & Customer Ser...

Recruitment Genius: Accounts Assistant - Fixed Term Contract - 6 Months

£15000 per annum: Recruitment Genius: One of the largest hospitality companies...

Recruitment Genius: Electricians - Fixed Wire Testing

£28000 - £32000 per annum: Recruitment Genius: As a result of significant cont...

Day In a Page

Seifeddine Rezgui: What motivated a shy student to kill 38 holidaymakers in Tunisia?

Making of a killer

What motivated a shy student to kill 38 holidaymakers in Tunisia?
UK Heatwave: Temperatures on the tube are going to exceed the legal limit for transporting cattle

Just when you thought your commute couldn't get any worse...

Heatwave will see temperatures on the Tube exceed legal limit for transporting cattle
Exclusive - The Real Stories of Migrant Britain: Swapping Bucharest for London

The Real Stories of Migrant Britain

Meet the man who swapped Romania for the UK in a bid to provide for his family, only to discover that the home he left behind wasn't quite what it seemed
Cheaper energy on the way, but it's not all sunshine and rainbows

Cheaper energy on the way, but it's not all sunshine and rainbows

Solar power will help bring down electricity prices over the next five years, according to a new report. But it’s cheap imports of ‘dirty power’ that will lower them the most
Katy Perry prevented from buying California convent for $14.5m after nuns sell to local businesswoman instead

No grace of God for Katy Perry as sisters act to stop her buying convent

Archdiocese sues nuns who turned down star’s $14.5m because they don’t approve of her
Ajmer: The ancient Indian metropolis chosen to be a 'smart city' where residents would just be happy to have power and running water

Residents just want water and power in a city chosen to be a ‘smart’ metropolis

The Indian Government has launched an ambitious plan to transform 100 of its crumbling cities
Michael Fassbender in 'Macbeth': The Scottish play on film, from Welles to Cheggers

Something wicked?

Films of Macbeth don’t always end well - just ask Orson Welles... and Keith Chegwin
10 best sun creams for body

10 best sun creams for body

Make sure you’re protected from head to toe in the heatwave
Wimbledon 2015: Nick Bollettieri - Milos Raonic has ability to get to the top but he must learn to handle pressure in big games

Nick Bollettieri's Wimbledon files

Milos Raonic has ability to get to the top but he must learn to handle pressure in big games
Women's World Cup 2015: How England's semi-final success could do wonders for both sexes

There is more than a shiny trophy to be won by England’s World Cup women

The success of the decidedly non-famous females wearing the Three Lions could do wonders for a ‘man’s game’ riddled with cynicism and greed
How to stop an asteroid hitting Earth: Would people co-operate to face down a global peril?

How to stop an asteroid hitting Earth

Would people cooperate to face a global peril?
Just one day to find €1.6bn: Greece edges nearer euro exit

One day to find €1.6bn

Greece is edging inexorably towards an exit from the euro
New 'Iron Man' augmented reality technology could help surgeons and firefighters, say scientists

'Iron Man' augmented reality technology could become reality

Holographic projections would provide extra information on objects in a person's visual field in real time
Sugary drinks 'are killing 184,000 adults around the world every year'

Sugary drinks are killing 184,000 adults around the world every year

The drinks that should be eliminated from people's diets
Pride of Place: Historians map out untold LGBT histories of locations throughout UK

Historians map out untold LGBT histories

Public are being asked to help improve the map